Advertisement
Screener

908 DEVICES INC. (MASS) Return on Tangible Equity

2.8 / 5 stars · 68/120 Roast Me

908 Devices Inc. Return Tang Equity

Return on tangible equity is the profit a company earns on the physical and financial capital its shareholders own, leaving out goodwill and other intangible assets, shown as a percentage. It is net income divided by tangible equity, which is shareholder equity minus goodwill and intangibles; the table shows both amounts. Because acquired goodwill is removed, it runs higher than ROE for companies that grew by acquisition, and it has no meaning when goodwill exceeds equity. Goodwill and intangibles are taken at the latest reported date on or before each equity date. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • 908 Devices Inc. return tang equity for the quarter ending 2026-06-30 was -49.09%, a change of -32.56% year-over-year.
  • 908 Devices Inc. return tang equity for the quarter ending 2026-03-31 was -36.62%, a change of -22.06% year-over-year.
  • 908 Devices Inc. return tang equity for the quarter ending 2025-12-31 was 18.17%, a change of 113.28% year-over-year.
  • 908 Devices Inc. return tang equity for the quarter ending 2025-09-30 was -4.17%, a change of 76.93% year-over-year.
  • 908 Devices Inc. return tang equity for fiscal 2025 was 18.17%, a change of 113.28% from fiscal 2024.
  • 908 Devices Inc. return tang equity for fiscal 2024 was -95.12%, a change of -70.40% from fiscal 2023.
  • 908 Devices Inc. return tang equity for fiscal 2023 was -24.72%, a change of -5.21% from fiscal 2022.
  • 908 Devices Inc. return tang equity for fiscal 2022 was -19.51%, a change of -9.18% from fiscal 2021.
Available history
2020-12-31 to 2026-06-30
Data captured

Historical Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2026-06-30-49.09%-$34.66M$70.6M
2026-03-31-36.62%-$36.07M$98.49M
2025-12-3118.17%$19.49M$107.29M
2025-09-30-4.17%-$4.13M$99.16M
2025-06-30-16.53%-$18.44M$111.56M
2025-03-31-14.56%-$17.69M$121.46M
2024-12-31-95.12%-$72.21M$75.91M
2024-09-30-81.10%-$60.19M$74.22M
2024-06-30-55.18%-$37.99M$68.84M
2024-03-31-24.97%-$34.79M$139.29M
2023-12-31-24.72%-$36.4M$147.26M
2023-09-30-25.46%-$38.76M$152.26M
2023-06-30-24.30%-$37.93M$156.11M
2023-03-31-22.65%-$36.68M$161.98M
2022-12-31-19.51%-$33.56M$172.06M
2022-09-30-15.19%-$27.24M$179.33M
2022-06-30-13.01%-$26.16M$201.12M
2022-03-31-12.33%-$25.49M$206.8M
2021-12-31-10.33%-$22.17M$214.6M
2021-09-30-23.56%-$28.93M$122.78M
2021-06-30-20.11%-$25.47M$126.67M
2021-03-31-11.96%-$15.95M$133.31M
2020-12-31-9.22%-$12.82M$139.04M

Annual Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2025-12-3118.17%$19.49M$107.29M
2024-12-31-95.12%-$72.21M$75.91M
2023-12-31-24.72%-$36.4M$147.26M
2022-12-31-19.51%-$33.56M$172.06M
2021-12-31-10.33%-$22.17M$214.6M
2020-12-31-9.22%-$12.82M$139.04M

Similar stocks

Stock NameCountryMarket CapPE Ratio
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
EyePoint, Inc. (EYPT)United States$0.314B-3.96
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15
Quanterix Corp (QTRX)United States$0.150B-1.65
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34
Precipio, Inc. (PRPO)United States$0.043B-36.70
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
ASTROTECH Corp (ASTC)United States$0.013B